Lars M. Wagner

3.6k citations

82 papers · 2.4k indexed · h-index 29

Impact in

Neurology top 2%
- Neuroblastoma Research and Treatments
Oncology top 5%
- CAR-T cell therapy research

Papers in

Neurology 31
- Neuroblastoma Research and Treatments 30
Oncology 32
- Lung Cancer Research Studies 11
- CAR-T cell therapy research 10

Co-authors: Timothy P. Cripe Mary K. Danks Clinton F. Stewart Mary Frances Wedekind Robert E. Goldsby Karen Albritton M. Beth McCarville Maryam Fouladi
Journals: Journal of Clinical Oncology (17 papers)Pediatric Blood & Cancer (15 papers)Journal of Pediatric Hematology/Oncology (5 papers)Cancer (4 papers)Clinical Cancer Research (3 papers)
Partner nations: United States Canada Switzerland

In The Last Decade

Lars M. Wagner

76 papers receiving 2.3k citations

Peers

Countries citing papers authored by Lars M. Wagner

Since Specialization

Citations

This map shows the geographic impact of Lars M. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars M. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars M. Wagner more than expected).

Fields of papers citing papers by Lars M. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars M. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars M. Wagner. The network helps show where Lars M. Wagner may publish in the future.

Co-authors

The 25 scholars most cited alongside Lars M. Wagner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lars M. Wagner Line = papers co-authored together Lars M. Wagner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Towards directed therapy for fusion-positive rhabdomyosarcoma Pharmacology & Therapeutics ·Alex Saul Redrován Chalán, Sapna Oberoi, Brian H. Ladle, V. Dejonghe, Lars M. Wagner, Angela N. Koehler, Corinne M. Linardic	2025	0
2	Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board Cancer ·Ajay Gupta, Nupur Gargate, Richard F. Riedel, M.J. Sciliano, Scott C. Borinstein, Michael S. Isakoff, Jamie M. Aye, Nino Rainusso, Amy E. Armstrong, Steven G. DuBois, Lars M. Wagner, Jeremy Rosenblum, Sarah Cohen‐Gogo, Catherine M. Albert, Leonhard, Rashmi Chugh, Yuko Fujimoto	2024	2
3	Adoption as an Alternative Family-Building Strategy: Perceptions of Female, Young Adult Cancer Survivors Receiving Gonadotoxic Treatments Journal of Adolescent and Young Adult Oncology ·Caroline S. Dorfman, Diah Vialita Dewi Ageng Jelly Purwanto, Ian Pj Alwayn, Rebecca A. Shelby, Julia T. Woodward, Kelly S. Acharya, Brittany A. Davidson, Lars M. Wagner, Cheyenne Corbett, Rachel A. Greenup	2024	0
4	Genetic variation near GRB10 associated with bone growth and osteosarcoma risk in canine and human populations Cancer Epidemiology ·尹炼, Tianzhong Yang, Эдуард Владимирович Гирусов, S. Andres Estrada, Helen M. Hansen, Adam J. de Smith, Libby M. Morimoto, Catherine Metayer, Quinn T. Ostrom, William C. Eward, M.T. Rizzo, Lars M. Wagner, Joseph L. Wiemels, Logan G. Spector, Kyle M. Walsh	2024	2
5	Comparison of oral aprepitant and intravenous fosaprepitant for prevention of chemotherapy-induced nausea and vomiting in pediatric oncology patients: a randomized phase III trial Translational Pediatrics ·Liting Yu, Zhuo Wang, محمد علی احمدی خواه, Jacqueline Artier, Lars M. Wagner, Shania Fajriati, Zhiling Li, Yijin Gao	2024	1
6	Structural and functional analysis of a new co-processed tableting excipient for food compaction processes Journal of Food Engineering ·Serveis Municipals de Mediació Intercultural, Lars M. Wagner, LI Ruijun, Vincent Cergolj, Arno Kwade, Jan Henrik Finke	2023	1
7	Risk of Surgical Intervention in Children with Diagnoses of Cancer and Preoperative Malnutrition: A National Analysis Journal of Pediatric Surgery ·Harold J. Leraas, Celina Ramjoué, Johnny Sjöström, Augustine Rimesh, Alonso Barrantes-Freer, Anna Hoover, Д. А. Бортновский, Krista Haines, Lars M. Wagner, Elisabeth T. Tracy	2023	3
8	Phase II trial of gemcitabine and nab‐paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation Pediatric Blood & Cancer ·Javier Oesterheld, Damon R. Reed, Bhuvana A. Setty, Michael S. Isakoff, Patrick Thompson, Hong Yin, Masanori Hayashi, David M. Loeb, Tiffany Smith, Prajna Bhunia, Brooke L. Fridley, Lars M. Wagner	2020	16
9	An evolutionary framework for treating pediatric sarcomas Cancer ·Damon R. Reed, Pradyumna Vasudeo Desale, D Brătucu, Brooke L. Fridley, Masanori Hayashi, Michael S. Isakoff, David M. Loeb, Prajna Bhunia, Ryan D. Roberts, Matteo Trucco, Lars M. Wagner, Mark G. Alexandrow, Robert A. Gatenby, Joel S. Brown	2020	31
10	Case 4: Gynecomastia in a 15-year-old Boy Pediatrics in Review ·Charles Guérin, Abdelaziz Mohamed Emam, John M. Draus, Lars M. Wagner	2020	0
11	<p>Management of recurrent Ewing sarcoma: challenges and approaches</p> OncoTargets and Therapy ·David Van Mater, Lars M. Wagner	2019	55
12	Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study Child s Nervous System ·Lindsey M. Hoffman, Maryam Fouladi, James M. Olson, Vinay M. Daryani, Clinton F. Stewart, Cynthia Wetmore, Mehmet Koçak, Arzu Onar‐Thomas, Lars M. Wagner, Sridharan Gururangan, Roger J. Packer, Susan M. Blaney, Amar Gajjar, Larry E. Kun, James M. Boyett, Richard J. Gilbertson	2015	41
13	A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Report Clinical Cancer Research ·Maryam Fouladi, John P. Perentesis, Lars M. Wagner, Alexander A. Vinks, Joel M. Reid, Charlotte H. Ahern, George Thomas, Carol A. Mercer, Darcy A. Krueger, Peter J. Houghton, L. Austin Doyle, Helen Chen, Brenda J. Weigel, Susan M. Blaney	2014	16
14	Impact of Voluntary Accreditation on Deficiency Citations in U.S. Nursing Homes The Gerontologist ·Lars M. Wagner, Shao‐Hua Su, Nicholas G. Castle	2012	18
15	A robotic-assisted laparoscopic approach for pediatric renal cell carcinoma allows for both nephron-sparing surgery and extended lymph node dissection Journal of Pediatric Surgery ·Nicholas G. Cost, James I. Geller, William DeFoor, Lars M. Wagner, Paul H. Noh	2012	29
16	New therapeutic targets for the treatment of high‐risk neuroblastoma Journal of Cellular Biochemistry ·Lars M. Wagner, Mary K. Danks	2009	84
17	Pilot Study to Evaluate MYCN Expression as a Neuroblastoma Cell Marker to Detect Minimal Residual Disease by RT-PCR Journal of Pediatric Hematology/Oncology ·Lars M. Wagner, Inna Girlitsky, Sylvie M. Guichard, Susana C. Raimondi, Victor M. Santana, Wayne L. Furman, Phillip Barnette, Mary K. Danks	2006	1
18	Impact of a Falls Menu-Driven Incident-Reporting System on Documentation and Quality Improvement in Nursing Homes The Gerontologist ·Lars M. Wagner, Elizabeth Capezuti, Jennifer Taylor, Richard W. Sattin, Joseph G. Ouslander	2005	41
19	Efficacy and toxicity of a virus-directed enzyme prodrug therapy purging method: preclinical assessment and application to bone marrow samples from neuroblastoma patients. PubMed ·Lars M. Wagner, Sylvie M. Guichard, Inna Girlitsky, Christopher L. Morton, S-T TAN, Richard A. Ashmun, Linda C. Harris, Peter J. Houghton, Philip M. Potter, Mary K. Danks	2002	27
20	Treatment of Metastatic Rhabdoid Tumor of the Kidney Journal of Pediatric Hematology/Oncology ·Lars M. Wagner, D. Ashley Hill, Christine Fuller, Márcia Alessandra Carneiro Pedrosa, José Miguel Baptista Proença Braz, Arie Perry, Jeffrey S. Dome	2002	45

About Lars M. Wagner

Lars M. Wagner is a scholar working on Neurology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Issues, ethics and legal aspects, having authored 82 papers that have together received 2.4k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (30 papers), Sarcoma Diagnosis and Treatment (22 papers), Cancer therapeutics and mechanisms (19 papers), Lung Cancer Research Studies (11 papers), CAR-T cell therapy research (10 papers), Cancer, Hypoxia, and Metabolism (8 papers), Glioma Diagnosis and Treatment (7 papers) and Lymphoma Diagnosis and Treatment (7 papers). The work is most often cited by research in Neurology (686 citations), Oncology (707 citations), Pulmonary and Respiratory Medicine (845 citations), Cancer Research (386 citations) and Genetics (224 citations). Lars M. Wagner has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Timothy P. Cripe, Mary K. Danks, Clinton F. Stewart, Mary Frances Wedekind, Robert E. Goldsby, Karen Albritton, M. Beth McCarville, Maryam Fouladi, David Van Mater and Susan M. Blaney. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, Journal of Pediatric Hematology/Oncology, Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact